A new study indicates that the drug suvorexant could reduce proteins associated with Alzheimer's by improving sleep quality.

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain ...

Serotonin is known by many names — in science as 5-hydroxytryptamine (5-HT) or enteramine, and in popular culture as the ‘feel good’ chemical or the ‘happy hormone’. Cameron Movassaghi ...

The study presents a valuable finding on the role of cholesterol-binding sites on GLP-1 receptors although the clinical ramifications are unclear and not eminent at this point. Based on the detailed ...

CD47 is found to play a pivotal role in this immunosuppression by inducing the production of amyloid-β (Aβ), which interacts with CD74 on B cells, leading to B-cell suppression and subsequent adaptive ...

PMN310 is uniquely designed to selectively target toxic oligomers of amyloid-beta, which we believe is a key differentiator ... antibodies and intrabodies against a pathogenic loss-of-structure ...

These engineered particles can incorporate one or more types of proteins or peptides along with other materials into a well-defined layered structure ... of the amyloid beta peptide, a protein ...

Department of Chemical Engineering, Stanford University, Stanford, California 94305, United States Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, ...

Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California 92093 , United States Department of Chemistry and Biochemistry, University ...

These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and ... are based on the new molecular understanding ...